Request Legal Help Now - Free

Zontivity Side Effects Legal News and Lawsuits

Were you looking for Pradaxa (bleeding deaths) or Coumadin (Warfarin - side effects) or Xarelto Blood Thinner Side Effects lawsuits?

Zontivity is a newer generation anticoagulant medication. Some anticoagulant medications have been linked to an increased risk of serious side effects, including uncontrolled bleeding and hemorrhaging in the brain. Lawsuits have been filed against the makers of some anticoagulant medications alleging patients were harmed by the use of such medications.


Send your Zontivity claim to a lawyer who will review your claim at NO COST or obligation.

Anticoagulants and Bleeding Risk

zontivitycasepage Anticoagulant medications are used to prevent heart attack and stroke by preventing the patient's blood from clotting. One potential side effect, however, is that an injury to a patient, even a seemingly minor one, could potentially result in uncontrolled bleeding, with serious consequences for the patients.

One anticoagulant medication, Warfarin, has been linked to an increased risk of bleeding but has an antidote, so if patients receive medical attention quickly enough, the bleeding can be stopped. Newer generation anticoagulant medications, including Xarelto and Pradaxa are linked to an increased risk of uncontrolled bleeding but currently have no known antidote.

Zontivity Side Effects

actos_warning_label_ In 2014, Zontivity (known generically as vorapaxar) was approved by the FDA as an anticoagulant to prevent stroke, myocardial infarction and cardiovascular death in certain patients. It is the first in a class of drugs called protease-activated receptor-1 antagonists.

At least one study, known as TRACER, was stopped early because of a suggested increased risk of major bleeding, including intracranial hemorrhage, in patients who received Zontivity, according to FDA briefing documents. Furthermore, patients in another study called TRA2P who had a history of stroke stopped being enrolled because of a potential increased risk of intracranial hemorrhage.

The TRA2P study suggested an increased risk of moderate or severe bleeding and further suggested an increased risk of intracranial hemorrhage. A news release from the FDA notes that Zontivity increases the risk of bleeding, including life-threatening and fatal bleeding, with bleeding being the most commonly reported adverse reaction linked to Zontivity.

Zontivity Legal Help

If you or a loved one has suffered similar Zontivity side effects, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.

Last updated on


Concerns about Anticoagulant Link to Bleeding Event
Concerns about Anticoagulant Link to Bleeding Event
June 18, 2015
New Orleans, LAAnticoagulant lawsuits have been filed against the makers of various newer generation anticoagulant makers alleging patients were not warned about the lack of an antidote to the medications. There are a variety of new generation anticoagulants, including Zontivity, Xarelto and Pradaxa. So far, no Zontivity lawsuits have been filed READ MORE


Posted by

after taking zontivity for 3 weeks,during the first week I had tremendous headaches and vomiting that burst the blood vessels in my face this continued until I visited my regular doctor that suggested I no longer take it.


Fields marked * are mandatory. Please read our comment guidelines before posting.


Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.
*Your Comment:

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.
Request Legal Help Now! - Free